SCM
ZLAB icon

Superstring Capital Management’s Zai Lab ZLAB Stock Holding History

Superstring Capital Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$2.41M – 48
2024
Q3 		$2.41M Buy
+100,000
New +$1.89M 2.11% 15

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Superstring Capital Management's ZLAB Position: Q2 2026 in Review

Superstring Capital Management reduced its Zai Lab (ZLAB) stake by 44% in Q2 2026, selling an estimated $2.37M and leaving 155,813 shares worth $2.96M. The position accounts for 1.87% of the portfolio, ranked #20.

Superstring Capital Management first reported a position in ZLAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.1M in Q3 2024. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Superstring Capital Management held 155,813 shares of Zai Lab worth $2.96M as of Q2 2026.
  • Superstring Capital Management sold 120,005 Zai Lab shares in Q2 2026, an estimated $2.37M.
  • Zai Lab made up 1.87% of Superstring Capital Management's portfolio in Q2 2026, its #20 holding.
  • Superstring Capital Management first reported a position in Zai Lab in Q2 2024 and has held it in 9 quarters since.
  • Superstring Capital Management's Zai Lab position peaked at $15.1M in Q3 2024.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.